Terug
31
Dagbereik
€ 33,38
€ 34,76
52-Weeksbereik
€ 22,66
€ 55,00
Volume
306.431
50D / 200D Gem.
€ 42,59
/
€ 35,79
Vorige Slotkoers
€ 34,31
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 763,0 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | 0,2 | 3,7 |
| Net Margin % | 0,2 | 3,9 |
| Rev Growth 5Y % | 1,2 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 55,25
+60.3%
Low: € 49,00
High: € 60,00
Forward K/W
19,6
Forward WPA
€ 1,75
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,2 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 2,53
€ 2,47 – € 2,58
|
1,4 B | 1 |
| FY2027 |
€ 2,09
€ 1,82 – € 2,49
|
1,3 B | 6 |
| FY2026 |
€ 1,75
€ 1,67 – € 1,85
|
1,2 B | 6 |
Belangrijkste Punten
Revenue grew 1,15% annually over 5 years — modest growth
Earnings declined -83,62% over the past year
ROE of 0,17% is below average
Debt/Equity of 0,17 — conservative balance sheet
Generating 86,89M in free cash flow
P/E of 763,02 — premium valuation
Groei
Revenue Growth (5Y)
1,15%
Revenue (1Y)6,53%
Earnings (1Y)-83,62%
FCF Growth (3Y)-21,11%
Kwaliteit
Return on Equity
0,17%
ROIC0,27%
Net Margin0,17%
Op. Margin0,44%
Veiligheid
Debt / Equity
0,17
Current Ratio1,43
Interest Coverage0,84
Waardering
P/E Ratio
763,02
P/B Ratio1,27
EV/EBITDA304,95
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,53% | Revenue Growth (3Y) | 1,63% |
| Earnings Growth (1Y) | -83,62% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,15% | Earnings Growth (5Y) | -59,71% |
| Profitability | |||
| Revenue (TTM) | 1,18B | Net Income (TTM) | 2,05M |
| ROE | 0,17% | ROA | 0,10% |
| Gross Margin | 42,49% | Operating Margin | 0,44% |
| Net Margin | 0,17% | Free Cash Flow (TTM) | 86,89M |
| ROIC | 0,27% | FCF Growth (3Y) | -21,11% |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 1,43 |
| Interest Coverage | 0,84 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 763,02 | P/B Ratio | 1,27 |
| P/S Ratio | 1,32 | PEG Ratio | -12,16 |
| EV/EBITDA | 304,95 | Dividend Yield | 0,00% |
| Market Cap | 1,57B | Enterprise Value | 1,57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,18B | 1,11B | 1,15B | 1,30B | 1,13B |
| Net Income | 2,05M | 12,53M | -20,37M | 5,65M | 77,85M |
| EPS (Diluted) | 0,04 | 0,27 | -0,45 | 0,12 | 1,62 |
| Gross Profit | 503,44M | 471,00M | 499,93M | 588,99M | 554,65M |
| Operating Income | 5,16M | 337.000,0 | -19,33M | -2,32M | 89,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,97B | 2,12B | 2,23B | 2,21B | 2,14B |
| Total Liabilities | 742,91M | 877,65M | 1,04B | 1,08B | 995,81M |
| Shareholders' Equity | 1,23B | 1,24B | 1,19B | 1,13B | 1,15B |
| Total Debt | 204,35M | 382,55M | 614,09M | 616,74M | 541,01M |
| Cash & Equivalents | 196,52M | 369,20M | 467,97M | 330,36M | 349,05M |
| Current Assets | 680,07M | 815,49M | 927,57M | 881,81M | 780,70M |
| Current Liabilities | 476,61M | 595,68M | 367,79M | 428,45M | 876,16M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#800 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026